| 2022 | SCI, SCIE, SSCI, A&HCI
| Mugosa S, Radosavljevic I, Sahman M, Djordjevic N, Todorovic Z. | Risk factors for adverse drug reactions associated with clopidogrel therapy | Open Med (Wars) |
| 2022 | SCI, SCIE, SSCI, A&HCI
| Šahman-Zaimović M, Mugoša S. | Comparative analysis of the use of non-steroidal anti-inflammatory drugs in Montenegro, Finland and Croatia in the period 2010-2019 | Eur Rev Med Pharmacol Sci |
| 2021 | SCI, SCIE, SSCI, A&HCI
| Snezana Mugosa, Zoran Todorovic, Jelena Cukic, Majda Sahman-Zaimovic, Natasa Djordjevic | ABCB1 polymorphism in clopidogrel-treated Montenegrin patients | Open Life Sciences |
| 2021 | SCI, SCIE, SSCI, A&HCI
| Mugoša S, Džamić Z, Šahman – Zaimović M, Lukovac-Janjić N | Adverse drug reactions associated with sunitinib therapy: characteristics and risk factors | Vojnosanitetski pregled |
| 2021 | SCI, SCIE, SSCI, A&HCI
| Sahman M, Mugosa S, Rancic N. | Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study | Front Public Health |
| 2018 | SCOPUS
| Majda Šahman Zaimovic, Sabina Salihbegović Šahman, Eva Zver | Analysis of the funding sources of health systems in the ex-yugoslavia countries | Medicinski časopis Srpsko lekarsko društvo podružnica Kragujevac |
| 2017 | SCI, SCIE, SSCI, A&HCI
| Snežana Mugoša, Maja Stankovic, Nemanja Turkovic, Majda Šahman-Zaimovic, Željka Bešovic, Milorad Drljevic | Pharmacovigilance as an imperative of modern medicine: Experience from Montenegro | Vojnosanitetski pregled |
| 2017 | SCI, SCIE, SSCI, A&HCI
| Šahman-Zaimović M, Vukmirović S, Tomić N, Stilinović N, Horvat O, Tomić L | Relationship between outpatient antibiotic use and the prevalence of bacterial infections in Montenegro | Vojnosanitetski pregled |
| 2016 | SCI, SCIE, SSCI, A&HCI
| Mugosa S, Sahman-Zaimovic M, Todorovic Z, Bukumiric Z, Radosavljevic I, Djordjevic N | Genetic and Non-Genetic Factors Affecting The Response To Clopidogrel Therapy | Clin Ther |
| 2015 | SCI, SCIE, SSCI, A&HCI
| B. Kucevic, M. Rolevski, M. Sahman-Zaimovic, Z. Besovic, S. Mugosa | Promoting public awareness of clinical trials in Montenegro | Clinical Therapeutics |
| 2015 | SCI, SCIE, SSCI, A&HCI
| Mugosa S, Todorovic Z, Sahman-Zaimovic, Radosavljevic I, Bukumiric Z,Djordjevic N | Factors affecting the development of adverse drug reactions of beta blockers | Clinical Therapeutics |
| 2011 | SCI, SCIE, SSCI, A&HCI
| Tomic Z, Mikov M, Sabo A, Milijasevic B, Sahman M, Andric V | PCV24 Pharmacoepidemiology and pharmacoeconomic aspects of use of ACE inhibitors in Serbia compared with Montenegro in 2009 | Value in Health |
| 2009 | SCI, SCIE, SSCI, A&HCI
| Golocorbin-Kon S, Mikov M, Arafat M, Lepojevic Z, Mikov I, Sahman-Zaimovic M, Tomic Z | Cefotaxime pharmacokinetics after oral application in the form of 3α,7α-dihydroxy-12-keto-5β-cholanate micro vesicles in rat | Eur J Drug Metab Pharmacokinet |
| 2008 | SCI, SCIE, SSCI, A&HCI
| Tomic Z, Milijasevic B, Sabo A, Lalosevic D, Jakovljevic V, Mikov M, Sahman M, Vasovic V | Diclofenac and ketoprofen liver toxicity in rat | Eur J Drug Metab Pharmacokinet |
